23:08:54 EDT Mon 27 Apr 2026
Enter Symbol
or Name
USA
CA



Ndatalyze Corp
Symbol NDAT
Shares Issued 41,327,425
Close 2026-04-27 C$ 0.09
Market Cap C$ 3,719,468
Recent Sedar+ Documents

Ndatalyze appoints Domitrovic as sales director

2026-04-27 20:44 ET - News Release

Mr. Jim Durward reports

NDATALYZE CORP. ANNOUNCES APPOINTMENT OF COMMERCIAL SALES DIRECTOR FOR THE EPITOME HOCKEY PLATFORM

Ndatalyze Corp. has appointed Nicholas Domitrovic as commercial sales director for its Epitome hockey performance predisposition platform called Epitome Predispositions.

Mr. Domitrovic is a recently retired professional hockey player with international experience in France's FFHG Division 1. A former dual-sport NCAA athlete in hockey and golf, he served as captain of both programs and earned recognition as a four-year all-academic conference selection and academic all American. He previously served as a lead ice hockey instructor at Bell Sensplex and as president of the Mental Health Club at Elmira College in New York.

Mr. Domitrovic holds a bachelor of arts in business administration (minor in finance) and is currently pursuing a master of applied health science (sports management) at Brock University, where he plays hockey for the Brock University Badgers. The Badgers were among the teams involved in the development of the Epitome hockey application.

James Durward, president of Ndatalyze, stated: "Epitome has broad applicability across human performance metrics, from sport through business, and Nick is a natural fit to lead Epitome's commercialization both in hockey and other prospective fields. His initial responsibilities will include redesigning the marketing platform and website, as well as on-boarding hockey academies, schools and junior league teams to the platform."

Reverse takeover update

The company remains committed to completing its previously announced reverse takeover transaction, and is currently finalizing the terms and conditions of a definitive agreement. Investors are reminded that only shareholders of Ndatalyze as of the date of the anticipated trading halt -- expected to occur upon announcement of the execution of the definitive agreement -- will be entitled to receive shares of the private Epitome entity to be spun out upon closing of the RTO.

About Ndatalyze Corp.

Ndatalyze is a technology company focused on developing health and performance-related solutions through the application of advanced artificial intelligence and biometric data analytics.

We seek Safe Harbor.

© 2026 Canjex Publishing Ltd. All rights reserved.